Page last updated: 2024-09-04

gemcabene and Elevated Cholesterol

gemcabene has been researched along with Elevated Cholesterol in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bays, HE; Dujovne, CA; MacDougall, DE; McKenney, JM; Nyberg, J; Schrott, HG; Zema, MJ	1
Bakker-Arkema, R; Hartman, D; Hermann, D; Mandema, JW; Milad, M; Sheiner, T; Wang, W	1
Amantea, M; Benincosa, LJ; Corrigan, BW; Ewy, W; Glue, P; Hutmacher, MM; Koide, H; Kowalski, KG; Lalonde, RL; Lockwood, PA; Marshall, SA; Miller, R; Milligan, PA; Nichols, DJ; Parivar, K; Tensfeldt, TG	1

Reviews

2 review(s) available for gemcabene and Elevated Cholesterol

Article	Year
Model-based development of gemcabene, a new lipid-altering agent. The AAPS journal, 2005, Oct-07, Volume: 7, Issue:3 Topics: Caproates; Dose-Response Relationship, Drug; Drugs, Investigational; Humans; Hypercholesterolemia; Hypolipidemic Agents; Models, Theoretical; Randomized Controlled Trials as Topic	2005
Model-based drug development. Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:1 Topics: Alzheimer Disease; Amines; Analgesics; Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caproates; Cholesterol; Clinical Trials as Topic; Cognition; Computer Simulation; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Approval; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Glycoproteins; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Meta-Analysis as Topic; Models, Biological; Models, Statistical; Muscarinic Agonists; Neuralgia, Postherpetic; Neutrophil Infiltration; Oximes; Pharmacokinetics; Pharmacology; Reproducibility of Results; Research Design; Stroke; United States; United States Food and Drug Administration	2007

Article

Year

Model-based development of gemcabene, a new lipid-altering agent.

The AAPS journal, 2005, Oct-07, Volume: 7, Issue:3

Topics: Caproates; Dose-Response Relationship, Drug; Drugs, Investigational; Humans; Hypercholesterolemia; Hypolipidemic Agents; Models, Theoretical; Randomized Controlled Trials as Topic

2005

Model-based drug development.

Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:1

Topics: Alzheimer Disease; Amines; Analgesics; Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caproates; Cholesterol; Clinical Trials as Topic; Cognition; Computer Simulation; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Approval; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Glycoproteins; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Meta-Analysis as Topic; Models, Biological; Models, Statistical; Muscarinic Agonists; Neuralgia, Postherpetic; Neutrophil Infiltration; Oximes; Pharmacokinetics; Pharmacology; Reproducibility of Results; Research Design; Stroke; United States; United States Food and Drug Administration

2007

Trials

1 trial(s) available for gemcabene and Elevated Cholesterol

Article	Year
Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol. The American journal of cardiology, 2003, Sep-01, Volume: 92, Issue:5 Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Caproates; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Male; Middle Aged; Treatment Outcome; Triglycerides	2003

Article

Year

Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.

The American journal of cardiology, 2003, Sep-01, Volume: 92, Issue:5

Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Caproates; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Male; Middle Aged; Treatment Outcome; Triglycerides

2003